Latest filing published 05 Apr 2016 for ARRAY BIOPHARMA INC, €8,876.
Insider track record
No signal scores available.
Andrews R. Robbins: trading record in brief
Andrews R. Robbins discloses dealings in Array Biopharma Inc to SEC (Form 4). Between 1 March 2015 and 1 April 2016, the trades on record add up to 5 filings.
The open-market record consists of 1 sale worth €159k, with no purchase. Outside the open market, there are 3 share grants and 1 option exercise.
The record was last updated on 5 April 2016 with a share grant (€8,876) in Array Biopharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andrews R. Robbins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,367 shares@ US$3.00100.0% of flowCommon StockSEC:0001562180-16-002096:0
- 39,375 shares0Common StockSEC:0001127602-15-013966:0
- 32,069 shares@ US$7.96Common StockSEC:0001104659-15-016814:0
- 10,493 shares@ US$7.96Common StockSEC:0001104659-15-016814:1
- 21,576 shares@ US$8.25Common StockSEC:0001104659-15-016814:2
5 of 5 declarations
